TY - T1的死亡率:一个被忽视的结果啊CS-treated severe asthma JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.01486-2017 VL - 50 IS - 5 SP - 1701486 AU - Bourdin, Arnaud AU - Molinari, Nicolas AU - Vachier, Isabelle AU - Pahus, Laurie AU - Suehs, Carey AU - Chanez, Pascal Y1 - 2017/11/01 UR - //www.qdcxjkg.com/content/50/5/1701486.abstract N2 - Severe asthma, especially if associated with a T2 phenotype, often responds well to new emerging therapies, which have led to a reduction in the use of systemic oral corticosteroids (OCS) [1]. However, OCS-dependent patients still exist and are affected by the well-known (and potentially severe) side effects of such dependency. Longitudinal data that document the outcomes, including death, for these patients are lacking [2]. Here, we present our findings from a long-term severe asthma cohort, which indicate that mortality is a critical issue for these patients.Findings from a long-term severe asthma cohort indicate mortality is a critical issue for OCS-dependent patients http://ow.ly/rO8e30fZrPo ER -